Corporate News 05-Nov-22
Orissa Minerals Development Company to discuss results
On 11 November 2022
Orissa Minerals Development Company will hold a meeting of the Board of Directors of the Company on 11 November 2022.
Previous News
Orissa Minerals Development Company reports standalone net loss of Rs 0.22 crore in the December 2018 quarter
( Results - Announcements 12-Feb-19 16:49 )
Orissa Minerals Development Company reports standalone net profit of Rs 7.33 crore in the March 2021 quarter
( Results - Announcements 30-Jun-21 08:12 )
Ganges Securities Ltd leads gainers in 'B' group
( Hot Pursuit - 27-Nov-20 12:15 )
Orissa Minerals Development Company to announce Quarterly Result
( Corporate News - 08-Nov-23 19:39 )
Orissa Minerals Development Company standalone net profit declines 6.63% in the June 2016 quarter
( Results - Announcements 09-Sep-16 21:01 )
Orissa Minerals Development Company schedules AGM
( Corporate News - 06-Dec-24 17:03 )
Orissa Minerals Development Co records 59% YoY decline in Q2 PAT
( Hot Pursuit - 21-Nov-24 11:45 )
Orissa Minerals Development Company to announce Quarterly Result
( Corporate News - 27-May-24 12:51 )
Orissa Minerals Development Company reports standalone net loss of Rs 0.08 crore in the June 2017 quarter
( Results - Announcements 11-Aug-17 17:30 )
Orissa Minerals Development Company to convene board meeting
( Corporate News - 05-Nov-19 16:25 )
Orissa Minerals Development Company to hold AGM
( Corporate News - 27-Aug-14 17:26 )
Other Stories
Board of Arkade Developers approves acquisition of Filmistan
03-Jul-25 11:06
FAST India partners with Indegene to accelerate biotech innovation in India
03-Jul-25 11:01
LMW schedules board meeting
03-Jul-25 09:15
Julien Agro Infratech announces board meeting date
03-Jul-25 09:15
Alembic Pharmaceuticals announces acquisition of Utility Therapeutics
03-Jul-25 09:15
Shriram Asset Mgt. Company schedules AGM
03-Jul-25 09:14
Ideaforge Technology to convene AGM
03-Jul-25 09:14
D-Link (India) to announce Quarterly Result
03-Jul-25 09:14
Tuni Textile Mills to conduct board meeting
03-Jul-25 09:14
Biocon Biologics receives EU marketing authorisation for Vevzuo® and Evfraxy® biosimilars of Denosumab
03-Jul-25 09:12
Back
Top
